Two new drugs for homozygous familial hyperchelesterolemia

Med Lett Drugs Ther. 2013 Apr 1;55(1413):25-7.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Anticholesteremic Agents / adverse effects
  • Anticholesteremic Agents / pharmacology
  • Anticholesteremic Agents / therapeutic use
  • Benzimidazoles / adverse effects
  • Benzimidazoles / pharmacology
  • Benzimidazoles / therapeutic use*
  • Cholesterol, LDL / blood
  • Drug Approval
  • Homozygote
  • Humans
  • Hyperlipoproteinemia Type II / drug therapy*
  • Hyperlipoproteinemia Type II / physiopathology
  • Oligonucleotides / adverse effects
  • Oligonucleotides / pharmacology
  • Oligonucleotides / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Anticholesteremic Agents
  • BMS201038
  • Benzimidazoles
  • Cholesterol, LDL
  • Oligonucleotides
  • mipomersen